ReportWire

Tag: patent

  • U.S. Trade Tribunal to Consider New Apple Watch Import Ban

    [ad_1]

    The U.S. International Trade Commission decided on Friday to hold a new proceeding to determine whether imports of Apple’s updated Apple Watches should be banned as part of a patent dispute with medical monitoring technology company Masimo.

    The ITC said in an order that it would investigate whether Apple Watches that were redesigned to circumvent a previous import ban issued by the commission still infringe Masimo patents covering blood-oxygen measurement technology.

    The commission set a target to finish the investigation within six months.

    Apple said the case was a meritless attempt to block its smartwatches’ blood oxygen feature and that Masimo had copied its watch design in order to bring the complaint.

    Apple, Masimo fighting on multiple fronts

    The case is part of a contentious, multi-front patent fight between Apple and Masimo, an Irvine, California-based medical monitoring technology company that has accused the tech company of hiring away its employees to steal its pulse-oximetry innovations.

    The commission blocked imports of Apple’s Series 9 and Ultra 2 smartwatches in 2023 after finding that Masimo’s patents were infringed. Apple removed blood-oxygen reading technology from its watches to avoid the ban, but reintroduced an updated version of the technology in August with approval from U.S. Customs and Border Protection.

    Masimo has sued Customs over the approval, while Apple has separately challenged the ITC’s ban at a federal appeals court.

    Masimo has also sued Apple in California federal court for patent infringement and trade-secret theft. A jury in Santa Ana determined separately on Friday that Apple owes $634 million in damages for infringing a Masimo patent.

    A California judge declared a mistrial in Masimo’s trade-secret case against Apple in 2023 after a jury failed to reach a unanimous verdict. Apple won a minimal $250 verdict against Masimo in Delaware last year in a countersuit over allegations that Masimo’s smartwatches infringe two Apple design patents.

    Reporting by Blake Brittain in Washington; Additional reporting by Dheeraj Kumar in Bengaluru; Editing by Rod Nickel and Shri Navaratnam

    [ad_2]

    Reuters

    Source link

  • Multnomah County Library System is New Home For Patents and Trademarks – KXL

    [ad_1]

    Oregon State University isn’t the only institution that will allow the public to apply for a patent or trademark. The Multnomah County Library system is partnering with the United States Patent and Trademark Office to become an official resource center.

    The county libraries will be able to connect the public with local patent lawyers, have discussion and provide searches about patents and trademarks, and help in the application process.

    Shawn Cunningham with the library says how this affiliation came about.

    “Multnomah County Library is always looking for ways to help patrons learn and create,” Cunningham said.

    “Becoming an official Patent and Trademark Resource Center for the U.S. Patent and Trademark Office is one new way that the library can help our community pursue their ambitions and goals,” Cunningham continued.

    He also teased some of the festivities that will be happening at Albina Library starting tomorrow.

    “We’ll have a range of programs that day, including a roundtable discussion with representatives from the U.S. Patent and Trademark Office,” Cunningham said.

    “People will be able to (also) connect with local trusted resources, like attorneys, who can help them protect their intellectual property,” Cunningham continued.

    Albina Library will mark the opening of the partnership starting at 12:30pm Wednesday.

    More about:

    [ad_2]

    Noah Friedman

    Source link

  • Truist innovates around Truist Client Pulse solution

    [ad_1]

    The AI-driven Truist Client Pulse tool is helping Truist boost its digital capabilities.  The tool provides client feedback from more than 30 million interactions from disparate channels, Michael Springs, senior associate general counsel at Truist, told Bank Automation News.  Currently in pilot, the solution “uses a hybrid of supervised and unsupervised machine learning models to […]

    [ad_2]

    Whitney McDonald

    Source link

  • Truist’s granted patents skyrocket 960% YoY in 2024

    [ad_1]

    Truist is prioritizing innovation and has seen a sharp increase in the number of patents it has been granted.  The $544 billion bank launched its patent program in 2022 as it looked to foster a more digital and innovative approach to banking, Michael Springs, senior associate general counsel at Truist, told Bank Automation News.  “Truist’s […]

    [ad_2]

    Whitney McDonald

    Source link

  • Inside Capital One’s innovation, patent strategy

    [ad_1]

    Big banks are positioning themselves as technology companies — and they have the patent portfolios to prove it.  Investments in technology in the past decade have “made banks key players in the technology ecosystem,” Rocky Berndsen, head of patent analytics at patent preparation and prosecution firm Harrity & Harrity, told Bank Automation News. Banks, he […]

    [ad_2]

    Whitney McDonald

    Source link

  • USPTO Issues Patent to Ideal Innovations for Handheld Integrated Targeting System (HITS)

    USPTO Issues Patent to Ideal Innovations for Handheld Integrated Targeting System (HITS)

    [ad_1]

    The U.S. Patent and Trademark Office (USPTO) issued a patent on June 4, 2024, (patent #US12,000,674), to Ideal Innovations, Inc. (I-3), called Handheld Integrated Targeting System (HITS). HITS facilitates increased accuracy for targeting drones and other Unmanned Aerial Systems (UAS) and represents a leap forward in the counter-UAS space.

    Modern conflicts have seen an increasing reliance on drone attacks and other uses of the technology. HITS is game-changing in that it gives soldiers an edge in countering these types of attacks, defeating drones and other UAS-type threats by vastly improving precision and success rate.

    “The rise of drone-based warfare and its escalating threat level was the impetus behind the HITS patent,” stated Bob Kocher, CEO of I-3. “We’re optimistic this concept can be implemented in real-world conflict scenarios to aid U.S. forces and our allies.”

    HITS works via an aiming system adapted to handheld weapons and includes a target detection and tracking system; an Inertial Measurement Unit (IMU) integrated with the target detection and tracking system, and the weapon launching system; and a fire control computer and a display system enabling the weapons launcher operator to point the weapon with the appropriate elevation and azimuth for the weapon projectile to intercept the intended target.

    I-3 is an inventions company working primarily with the Department of Defense. Mr. Kocher is a West Point graduate who served 21 years in the military with six years at the Defense Advanced Research Projects Agency (DARPA), where he gained a reputation as a rapid solution innovator. Other I-3 efforts include secure access systems, early identification of a person’s natural ability through neuroscience, and temperature tracking to help fight infectious diseases.

    For any inquiries regarding HITS, please contact Ideal Innovations, Inc. at info@idealinnovations.com

    Source: Ideal Innovations, Inc.

    [ad_2]

    Source link

  • 1 in 5 BofA patents AI-focused | Bank Automation News

    1 in 5 BofA patents AI-focused | Bank Automation News

    [ad_1]

    To keep up with consumer demand for digital capabilities, Bank of America’s inventors focus on solving client problems and removing friction through innovation and patent efforts.  In 2023, the $3.2 trillion bank was granted 644 patents, up 6% year over year from 2022, according to a bank press release.  The bank’s inventors work on identifying […]

    [ad_2]

    Whitney McDonald

    Source link

  • Google makes bid to resolve competition concerns in Germany over its automotive services bundling | TechCrunch

    Google makes bid to resolve competition concerns in Germany over its automotive services bundling | TechCrunch

    [ad_1]

    Following competition objections raised on Google in Germany this summer over bundling of services including Google Maps via its Android-based in-car infotainment system software, known as Google Automotive Services (GAS), the tech giant has made an offer of some service unbundling and the removal of contractual restrictions it applies to vehicle makers in a bid to settle the regulatory intervention.

    Google’s proposed remedies will be put to car makers in a market test by the German competition regulator before it decides whether or not they resolve issues it’s identified.

    Back in June, the country’s Federal Cartel Office (FCO) sent a statement of objections to the tech giant over how it operates GAS — specifically calling out Google’s bundling of Google Maps, Google Play and Google Assistant in the offer to vehicle manufacturers.

    The statement also highlighted Google’s practice of only granting vehicle makers a share of ad revenue if they refrained from pre-installing other voice assistants next to its own voice AI. Another concern the FCO raised is GAS licence holders are required by Google to set its bundled services as the default or else display them prominently. It also objected to Google limiting or refusing to allow interoperability of services included in GAS with third-party services.

    At the time, the FCO said its preliminary view of Google’s practices around GAS were that they do not comply with Germany’s competition rules for large digital companies — which give the FCO greater leeway to intervene when it suspects competition is being harmed.

    “In particular, we take a critical view of Google offering its services for infotainment systems as a bundle only, as this reduces its competitors’ chances to sell their competing services as individual services,” the FCO said in the summer.

    The regulator said it will now carefully examine Google’s offer to decide if it fixes the competition concerns by offering an adequate level of unbundling of its own services from its in-car infotainment platform.

    “We are particularly concerned about the compulsory bundling of services with great market strength and reach with services that are less strong. This conduct in particular can result in expanding market power and strengthening ecosystems; it is a particularly problematic way of ‘penetrating’ markets,” FCO president Andreas Mundt said in a press release to announce Google’s offer Wednesday. “It could reduce competitors’ opportunities to sell competing services. We are now going to examine very closely whether Google’s proposals are capable of effectively terminating the practices that have raised concerns.”

    The remedies Google has proposed to address the FCO’s competition concerns are to separately offer three further products: Google Maps OEM Software Development Kit, Google Play Store and Cloud Custom Assistant, in addition to the GAS product bundle — which it says will enable vehicle makers to develop a maps and navigation service with functionalities equivalent to those offered by Google Maps.

    The addition of the Google Play Store would also allow end users to download a wider choice of third party apps, to reduce concerns about them being nudged towards using Google’s own apps. The Cloud Custom Assistant is described as “a proprietary AI voice assistant solution” for use in vehicles to enable car makers to offer competing assistants.

    The tech giant has also proposed to remove contractual provisions it imposes on sharing ad revenue on the condition its own Google Assistant voice AI is exclusively pre-installed in the GAS infotainment platform.

    “Google is also prepared to eliminate its contractual provisions on setting Google services as default applications or displaying them prominently in the infotainment platform,” the FCO also noted. “Lastly, Google is prepared to enable licence holders to combine Google Assistant services with other maps and navigation services and provide for the technical preconditions to create the necessary interoperability.”

    “Based on the results of the market tests the Bundeskartellamt [FCO] will decide whether Google’s proposals are generally capable of dispelling the concerns that have been addressed. The question of whether Google’s proposals will result in an unbundled offering of Google’s services in the automotive sector will be decisive in this context,” it added.

    Google was contacted for comment on its proposals.

    The tech giant’s business was designated as subject to Germany’s special competition abuse control regime back in January 2022. Since then the FCO has extracted a number of concessions from it over how it operates — including, this fall, securing agreement on a reform of Google’s data terms under which it will provide users with more choice over how it can use their information. Last year, Google also offered to limit how it displays news content its licensed from third party publishers in search results in a bid to resolve the regulator’s concerns around self-preferencing.

    The German digital competition reboot only applies to designated tech giants locally, in the market — although companies may opt to apply product changes globally to manage operational complexity (as, for example, Meta did this summer with the launch of a new account center that lets users refuse its cross-site tracking, after an FCO intervention, which the company said would be rolled out globally).

    The European Union also recently implemented its own ex ante competition reformed, in the form of the Digital Markets Act (DMA), which is aimed at so-called Internet gatekeepers. So the FCO’s enforcements on Big Tech offer a glimpse of the types of actions that may be coming down the pipe across the bloc next year when the deadline for compliance kicks in for the six in-scope DMA gatekeepers and their 22 core platform services — a list which includes Google Maps, Google Play, Google Shopping, Google ads, Google Chrome, Google Android, Google search and the Google-owned video sharing platform, YouTube.

    Notably the EU has not designated GAS a core platform service — which may, in part, explain the FCO’s attention on it here, as competition regulators in the bloc work to avoid duplication in their interventions. (Germany being a major car maker is also likely driving its oversight of Google’s automotive software and services.)

    And while the FCO also opened a proceeding on Google Maps in June 2022 that was (shortly) before the DMA was approved by the bloc’s co-legislators.

    The pan-EU regulation, meanwhile, started to apply, in May 2023. But the deadline for DMA gatekeepers to come into compliance is March 2, 2024 — so the full EU-wide Big Tech competition reboot won’t be up and running until next year. Which may give the FCO reason enough to continue its scrutiny of Google Maps in the meanwhile. (On this front the German regulator has also said it will continue to “cooperate closely” with EU competition authorities on regulating the digital economy.)

    As of June 2023, the FCO said it would keep investigating Google’s terms of use for the Google Maps Platform (GMP), saying then that its preliminary assessment is the tech giant would need to put an end to restrictions on combining its own GMP map services with third-party map services.

    “These restrictions may impede competition between applications relating to map services as used by logistics, transport and delivery service providers, for instance,” the FCO posited at the time. “They may also have a negative effect on competition between services for infotainment systems in vehicles because they make it more difficult for map service providers to develop effective alternatives to Google Maps.”

    The ex ante competition law reforms in Germany and across the EU aim to curb abusive behaviors by digital giants that may further entrench their massive market power — with European regulators hoping these more proactive interventions can do a better job of correcting imbalances in the digital economy than classical competition enforcement has been able to achieve. (A related example of classical enforcement is the $123M fine levied on Google by Italy’s competition watchdog, back in May 2021, over restrictions it had applied to a third party app maker via the Android Auto in-car software.)

    [ad_2]

    Natasha Lomas

    Source link

  • Apple has halted Watch Series 9 and Ultra 2 online sales | TechCrunch

    Apple has halted Watch Series 9 and Ultra 2 online sales | TechCrunch

    [ad_1]

    As promised, Apple has officially removed the Watch Series 9 from its online shop. Word on the surprise move arrived earlier this week, when the company confirmed that an ongoing patent dispute has forced it to pause sales of the flagship smartwatch. Click through to the site and you’ll find the words “Currently Unavailable” in the place of a Buy button.

    The Apple Watch Ultra 2 is similarly unavailable. You can, however, still buy the entry-level Apple Watch SE, likely owing to the product’s relatively limited on-board health metrics. You can also still pick up the Series 9 through other online sources. Amazon, for instance, is still promising a pre-Christmas delivery in some areas.

    The wearable will also still be available at brick and mortal Apple Store locations until Christmas Eve. If you already ordered the watch online for an in-store pickup, you can still do so through December 24, the company confirmed with TechCrunch.

    Apple’s patent battle with health tech company Masimo has been well-documented for the past couple of years. Even while Apple lost a few key rulings, however, Monday’s announcement still came as a surprise to many, given its unprecedented nature.

    In a statement provided to TechCrunch earlier this week, the company noted that it would continue to fight the decisions:

    A Presidential Review Period is in progress regarding an order from the U.S. International Trade Commission on a technical intellectual property dispute pertaining to Apple Watch devices containing the Blood Oxygen feature. While the review period will not end until December 25, Apple is preemptively taking steps to comply should the ruling stand. This includes pausing sales of Apple Watch Series 9 and Apple Watch Ultra 2 from Apple.com starting December 21, and from Apple retail locations after December 24.

    Apple’s teams work tirelessly to create products and services that empower users with industry-leading health, wellness, and safety features. Apple strongly disagrees with the order and is pursuing a range of legal and technical options to ensure that Apple Watch is available to customers.

    Should the order stand, Apple will continue to take all measures to return Apple Watch Series 9 and Apple Watch Ultra 2 to customers in the U.S. as soon as possible.

    At the heart of the battle is an optical image sensor used to monitor a wearer’s heart rate. Apple has employed similar technology dating back to 2020 with the arrival of the Series 6. Among other things, Masimo has accused the hardware giant of poaching key talent. It claims that Apple, “began hiring Masimo employees, starting with Masimo’s Chief Medical Officer.”

    There’s never a great time to stop selling one of your biggest products, but the holiday season is especially problematic. While Apple was able to keep sales open down to the wire, some folks may find themselves unwrapping a raincheck this year.

    [ad_2]

    Brian Heater

    Source link

  • Bernie Sanders Demands Probe of Proposal To Patent Taxpayer-Funded Cancer Drug | High Times

    Bernie Sanders Demands Probe of Proposal To Patent Taxpayer-Funded Cancer Drug | High Times

    [ad_1]

    Sen. Bernie Sanders is once again keeping drug makers in check, suggesting that people living with cancer are being preyed on by greedy interests.

    On Monday, Sanders demanded a Department of Health-led investigation into a proposal to grant a company with an exclusive patent license for cancer treatment and methods, produced with public resources and a potential conflict of interest.

    The sexually transmitted infection Human papillomavirus (HPV) can lead to six types of cancer and most cervical cancer, the National Cancer Institute (NCI) reports. It can be dormant for years or cause genital warts or worse. Last month, National Institutes of Health (NIH) proposed granting Kingston, New Jersey-based Scarlet TCR a patent for a T-cell therapy for HPV, which has undergone a Phase I trial and has a Phase II trial scheduled to conclude in 2025.

    There’s no cure for HPV, but drug developers are examining T-cell therapies to combat HPV and the cancers it leads to, including Scarlet TCR. Sometimes they’re gene-engineered. (CBD is also being explored for its potential to inhibit cervical cancer cells.) 

    There’s a problem though. The patent proposal and the company’s ties to an ex-government employee and other inconsistencies were revealed in an Oct. 18 report by The American Prospect. The NIH quietly applied to be granted “an exclusive patent for a cancer drug, potentially worth hundreds of millions or even billions of dollars, to an obscure company staffed by one of its former employees,” The American Prospect reports.

    Sanders, chairman of the Senate Health, Education, Labor, and Pensions (HELP) Committee, demanded a probe of the patent proposal in an Oct. 23 letter to Christi Grimm, who is inspector general of the U.S. Department of Health and Human Services. The HELP committee also announced Sander’s open letter on Oct. 23.

    Sanders suggested the NIH is allowing a company to take advantage of a life-saving cancer drug.

    “I am growing increasingly alarmed that not only has the NIH abdicated its authority to ensure that the new drugs it helps develop are reasonably priced, it may actually be exceeding its authority to grant monopoly licenses to pharmaceutical companies that charge the American people, by far, the highest prices in the world for prescription drugs,” Sanders wrote. “One particularly egregious example has recently been brought to my attention that I believe demands your immediate attention.”

    Sanders argued that the NIH should be doing more to lower the cost of drug therapy.

    “There does not appear to be anything reasonable and necessary about granting a monopoly for a treatment that was invented, manufactured and tested by the NIH, is already in late stage trials and could potentially enrich a former NIH employee who was one of the major government researchers of this treatment,” Sanders wrote. “Based on current law and the best interest of U.S. taxpayers who paid for this cancer therapy, it would seem to make more sense for the NIH to offer non-exclusive licenses so that multiple manufacturers can produce this important cancer therapy at reasonable and affordable prices. The apparent abuse of the system by the NIH with respect to the exclusive patent license for this cancer therapy is so egregious that it has been characterized as a ‘how-to-become-a-billionaire program run by the NIH.’”

    “If accurate,” Sanders wrote, “that would be absolutely unacceptable. The NIH should be doing everything within its authority to lower the outrageously high price of prescription drugs. It should not be granting a monopoly on a promising taxpayer-funded therapy that could cost hundreds of thousands of dollars for cancer patients in a way that appears to exceed its statutory authority.”

    The American Prospect story pointed out that the NIH offering an exclusive license for a cancer treatment to a company with no website or SEC filings staffed by a former NIH employee

    More Ethical Drug Research

    There is historical precedence on life-saving drugs or therapies that didn’t need a patent: On Jan. 23, 1923, Sir Frederick G. Banting, James B. Collip, and Charles Best, discoverers of insulin, were awarded U.S. patents on insulin and the methods used. They all sold these patents to the University of Toronto for $1 each. Banting said, “Insulin does not belong to me, it belongs to the world.” 

    While things have changed and the price of insulin skyrocketed, new efforts are being made by the drug’s top three makers to make insulin affordable once again.

    When the polio vaccine was found to be 90% effective, its discoverer wasn’t in it for the money. On April 12, 1955, Edward R. Murrow asked Jonas Salk who owned the patent to the polio vaccine. “Well, the people, I would say,” Salk responded. “There is no patent. Could you patent the sun?”

    In today’s pharmaceutical world, some of those values are lost.

    [ad_2]

    Benjamin M. Adams

    Source link

  • Vaya Space Awarded Multiple Patents for Vortex-Hybrid Engine Technology

    Vaya Space Awarded Multiple Patents for Vortex-Hybrid Engine Technology

    [ad_1]

    Press Release


    Aug 9, 2022

    Vaya Space, the vortex-hybrid engine rocket company and emerging leader in sustainable space access, announced today that the United States Patent and Trademark Office (USPTO) has awarded two patents to the Company on its breakthrough vortex-hybrid propulsion technology. 

    Privately held Vaya Space, with operations in both the U.S. and Brazil, has recently emerged as one of the leaders in the space industry and small satellite launch sector. The Company took a technology-first and different approach than many of its well-funded competitors, and as such has recently gained credibility from numerous industry leaders through recent agreements with NASA and major satellite customers that have selected Vaya Space as their launch provider for their constellations.   

    The Company’s first patent was awarded for its unique production process of its 3D-printed fuel grain that enables higher performance through uniform burn throughout the entirety of the engine. The second patent protects Vaya’s vortex flow field injection system design. The vortex flow of liquid oxygen through the 3D lathe printed rocket engine combines with Vaya’s other technologies to deliver more than 110 kN of thrust per engine, up to 350 seconds of ISP, and eliminates the instability and other issues that have plagued hybrid engines of the past decades.  

    Rob Fabian, Chief Operating Officer of Vaya Space, commented, “These two patent awards are a testament to the world-class engineering team at Vaya, and we are just getting started. Breakthrough doesn’t begin to define what we have recently accomplished. We see no barrier to transforming this and adjacent industries, and expect to make a difference for the environment in the process.”   

    Vaya’s rocket engines are produced using more than 20 metric tons of recycled thermoplastics and deliver industry-leading payload performance at a substantially lower cost than competitors. Vaya’s engines have zero TNT explosive equivalency and utilize materials that are non-toxic, non-hazardous, and require no special handling, storage or transportation. Vaya’s rocket engines use substantially fewer components resulting in improved reliability, are far less costly to produce, and operate with substantially lower emissions.  

    The awarding of Vaya’s two patents, multiple additional intellectual property in its pipeline, and the recent contracts and agreements with satellite customers and NASA have positioned Vaya as not just the greenest rocket company in the industry, but also the emerging leader and low-cost provider in the sector. 

    About Vaya Space, Inc.

    Vaya Space is a privately owned, vortex-hybrid rocket company based on the Space Coast of Florida with subsidiary operations in Brazil. Vaya Space has developed breakthrough and patented technologies that transform access to space. Vaya was created in 2017 by Sid Gutierrez, former Space Shuttle Commander and NASA’s first U.S.-born Hispanic astronaut. Launch Command’s final words to Sid at liftoff were “Vaya con Dios” vs. its traditional “Godspeed,” and shortly after this inspiration, Vaya was born.

    Vaya is a purpose-driven, sustainability focused, and environmentally conscious enterprise dedicated to making a difference for humankind. Vaya Space competes within the small satellite launch sector of the space industry, a market estimated to grow to $1 trillion over the next decade. Vaya’s unique vortex-hybrid rocket utilizes the equivalent of two million recycled plastic bottles per launch and overcomes the costs and other issues associated with traditional liquid or solid rockets to transform the safety, affordability, and sustainability of the industry.

    Additional information found at vayaspace.com.

    For inquiries, please contact:

    Vaya Space Investor Relations
    Kevin Lowdermilk
    +1 703 346-6826
    Kevin.Lowdermilk@VayaSpace.com   

    Vaya Space Media Relations 
    Mary Baldino
    +1 321 270-1478
    Mary.Baldino@VayaSpace.com

    Source: Vaya Space

    [ad_2]

    Source link

  • Schwegman Named in Top 25 Firms for Minority Attorneys

    Schwegman Named in Top 25 Firms for Minority Attorneys

    [ad_1]

    Press Release



    updated: Jul 17, 2019

    ​​​Schwegman Lundberg & Woessner is pleased to have been recognized as being among the top 25 law firms within its size category in the U.S. for minority attorneys, as reported by Law360 on July 7, 2019.

    “Both minority and gender diversity and inclusion are the focus of concerted efforts at Schwegman,” said Theresa Stadheim, Schwegman Principal and Diversity and Inclusion Steering Group member. “Schwegman has been very generous in providing support for diversity and inclusion events and has been visionary in its efforts, both nationally and locally, to get minorities and women interested in STEM careers at all levels.”

    Steven Lundberg, Managing Principal, commented: “We have been very active in efforts for fostering a culture of diversity and inclusion. Diversity can be particularly challenging in our demographic, since our intellectual property boutique firm is focused toward patent prosecution and our clients are somewhat skewed toward electrical and software technologies. While we have gained from a more diverse demographic in our San Jose office, and via our satellite attorney program that allows attorneys to work remotely from their preferred geographic locations, we continue to place great emphasis on diversity and inclusion at all locations and levels of our firm.”

    Suneel Arora, Schwegman Principal and Hiring Committee member, elaborated further: “Diversity is an ongoing effort that is discussed at every firm Board meeting and considered throughout our recruiting process, but I believe that it is our inclusive firm culture and excellent track record of retaining attorneys that will make our efforts successful and sustainable. I can personally attest to the opportunities for growth and success that are available to all and that are actively fostered at Schwegman. Moreover, our flat organization and the respect and autonomy accorded to all attorneys (and staff) makes it easier for minority attorneys to succeed.”

    “At Schwegman, attorneys have the ability to choose which technologies and clients are the best fit for their skills and interests, which is paramount to success, satisfaction, and longevity in our profession,” added Andre Marais, Schwegman Board and Diversity and Inclusion Steering Group member. “We don’t try to micromanage to achieve over-granular diversity objectives. Instead, we try to focus on recruiting, mentoring, and promoting with a focus on supporting individual team members, which we view as our best path to success for our entire team.”

    Further extensive information about ongoing diversity and inclusion efforts at Schwegman can be found here.

    Schwegman Lundberg & Woessner is an international intellectual property law firm that offers a full range of procurement and advanced portfolio management services.

    Media Contact:
    ​Suneel Arora
    ​Phone:  612-373-695
    ​Email: sarora@slwip.com

    Source: Schwegman Lundberg & Woessner

    [ad_2]

    Source link

  • JUST CONFIRMED – PTAB Chief Judge to Speak at Momentum’s Complimentary IP Counsel Exchange

    JUST CONFIRMED – PTAB Chief Judge to Speak at Momentum’s Complimentary IP Counsel Exchange

    [ad_1]

    Press Release


    Jul 14, 2016

    ​​​​​Momentum announced that Hon. David P. Ruschke, newly confirmed Chief Judge for the Patent and Trial Appeal Board (PTAB) will be speaking at Momentum’s IP Counsel Exchange taking place on December 1, 2016 in New York City.

    Dr. Ruschke will join a panel of his peers on the topic, Cross-Jurisdictional IP Litigation Interplay – Pet Peeves from the Bench on Timing, Discovery, Evidence, Claim Construction and the Management of Joint Proceedings – Practice Recommendations for Counsel from the Federal District Court, PTAB and ITC Bench.

    As Chief Judge, Dr. Ruschke manages the PTAB as it conducts trials, including inter partes, post-grant, and covered business method patent reviews and derivation proceedings, hears appeals from adverse examiner decisions in patent applications and reexamination proceedings, and renders decisions in interferences. In his previous role, Dr. Ruschke managed the intellectual property portfolio of Medtronic’s CSH business unit, with sales in excess of $3 billion. As Chief Patent Counsel, Dr. Ruschke participated in numerous patent appeals, interferences, post grant reviews, inter partes reviews, and covered business method patent reviews.

    Additional topics to be explored at the IP Counsel Exchange will include –

    ·      PTAB Litigation Crash Course: A Litigator’s Guide to Obtaining Successful Results at the PTAB
    ·      In-House Benchmarking – Strategies for Using IP as a Catalyst for Your Business
    ·      Building Your IP Litigation Dream Team – Tips for Selecting, Screening & Managing Outside Counsel to Oversee a Diverse IP Litigation Docket
    ·      Settlement & Appeals: When and How to Approach Settlement and Perspectives on the Treatment of IP Proceedings By Way of Appeal – From the Federal Circuit to the Supreme Court

    To view the most up-to-date program agenda, confirmed speaker list and reserve space for you and your colleagues in your IP department, visit the event site at ptabevents.com​ or call (646) 807-8555. Registration to this event is complimentary and only offered to in-house IP executives and corporate patent counsel.

    About Momentum

    Momentum is a leading international event creation and execution specialist working with numerous partners in order to bring their brands to life through customized live-event experiences. With an emphasis on rigorous research and world-class customer service, its team comprises many of the leading names in event creation and execution. For more information about Momentum, visit momentumevents.com.

    Momentum contact:

    Julia Guarini
    Marketing Manager
    Momentum
    julia@momentumevents.com

    Source: Momentum

    [ad_2]

    Source link